Advisor Resource Council Dexcom Inc Transaction History

Advisor Resource Council

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	SELL	$114.22 - $140.1 $1.4 Million - $1.72 Million	-12,263 Reduced 70.37%	5,164 $716,000
Q4 2023 Jan 12, 2024	BUY	$75.49 - $124.16 $1.12 Million - $1.85 Million	14,889 Added 586.64%	17,427 $2.16 Million
Q3 2023 Oct 24, 2023	BUY	$86.06 - $137.93 $218,420 - $350,066	2,538 New	2,538 $236,000
Q2 2021 Aug 13, 2021	BUY	$80.99 - $107.93 $2,753 - $3,669	34 New	34 $3,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Advisor Resource Council, based on Form 13F filings with the SEC.

Stay updated on Advisor Resource Council with notifications on news.